Kinsale Capital Group Inc. Has $16.01 Million Stock Position in UnitedHealth Group Incorporated $UNH

Kinsale Capital Group Inc. raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 13.4% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 38,510 shares of the healthcare conglomerate’s stock after acquiring an additional 4,557 shares during the quarter. UnitedHealth Group accounts for 2.1% of Kinsale Capital Group Inc.’s holdings, making the stock its 10th largest position. Kinsale Capital Group Inc.’s holdings in UnitedHealth Group were worth $16,006,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Sarver Vrooman Wealth Advisors acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $25,000. Anfield Capital Management LLC lifted its position in UnitedHealth Group by 220.0% in the fourth quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock worth $26,000 after purchasing an additional 55 shares during the period. Joseph Group Capital Management acquired a new stake in UnitedHealth Group during the fourth quarter worth $27,000. Nalls Sherbakoff Group LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at $27,000. Finally, Lifetime Wealth Management P.C. acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $29,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Down 1.7%

NYSE UNH opened at $395.02 on Tuesday. The stock’s 50 day simple moving average is $415.52 and its 200 day simple moving average is $353.65. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.78. UnitedHealth Group Incorporated has a one year low of $255.96 and a one year high of $461.62. The firm has a market cap of $354.57 billion, a PE ratio of 25.42, a price-to-earnings-growth ratio of 1.40 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, topping analysts’ consensus estimates of $4.94 by $1.44. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The company had revenue of $112.03 billion for the quarter, compared to analyst estimates of $110.81 billion. During the same quarter in the previous year, the firm earned $4.08 earnings per share. The business’s revenue was up .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 19.69 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th will be given a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Monday, September 14th. UnitedHealth Group’s dividend payout ratio is presently 59.72%.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 5th. The shares were sold at an average price of $410.00, for a total value of $205,000.00. Following the completion of the sale, the chief executive officer owned 16,497 shares of the company’s stock, valued at $6,763,770. This trade represents a 2.94% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 0.19% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of brokerages have commented on UNH. Wall Street Zen upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. DA Davidson set a $512.00 target price on UnitedHealth Group in a report on Tuesday, July 21st. Weiss Ratings lowered UnitedHealth Group from a “hold (c)” rating to a “hold (c-)” rating in a research note on Tuesday, July 28th. Oppenheimer increased their price objective on UnitedHealth Group from $420.00 to $500.00 and gave the stock an “outperform” rating in a research note on Friday, July 17th. Finally, HSBC boosted their target price on shares of UnitedHealth Group from $300.00 to $380.00 and gave the company a “hold” rating in a research note on Monday, July 6th. Two analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $455.92.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth authorized a dividend, reinforcing shareholder returns and signaling confidence in its financial position. However, the announcement comes amid an ongoing governance lawsuit, which may limit its positive impact. UnitedHealth Group Authorizes Dividend Amid Governance Lawsuit
• Positive Sentiment: Wall Street’s average brokerage recommendation remains favorable, suggesting analysts believe UnitedHealth’s valuation and earnings outlook could support the shares. The bullish view is tempered by the tendency of sell-side recommendations to skew optimistic. Wall Street Bulls Look Optimistic About UnitedHealth
• Neutral Sentiment: The expected guilty plea by Luigi Mangione in the federal case involving the killing of UnitedHealthcare CEO Brian Thompson could bring additional clarity to a high-profile event, but it does not materially change UnitedHealth’s operating outlook. Luigi Mangione Reportedly Set to Plead Guilty
• Negative Sentiment: A shareholder lawsuit alleges UnitedHealth misled investors, failed to address governance and cybersecurity weaknesses, and discontinued an internal Medicare billing audit before the Change Healthcare cyberattack. The claims increase potential legal, regulatory and reputational risks. Investor Suit Says UnitedHealth Ignored Governance and Cybersecurity Gaps
• Negative Sentiment: A derivative lawsuit reportedly says executives knew that patients won roughly 90% of appeals against AI-generated claim denials. The allegation raises concerns about the accuracy of automated utilization management, potential compliance costs and damage to UnitedHealth’s reputation. UNH Patients Win 90% of AI Denial Appeals
• Negative Sentiment: An investor analysis argues that margin recovery is already reflected in UnitedHealth’s valuation, leaving future earnings growth as the next major test. This limits upside if revenue or membership growth disappoints. UnitedHealth Margin Recovery Is Priced In

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.